OrthoPediatrics
(NASDAQ:KIDS)
$29.90
0[0.00%]
At close: Apr 17
$29.90
0[0.00%]
PreMarket: 4:00PM EDT

OrthoPediatrics Stock (NASDAQ:KIDS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
▲▼
ticker
▲▼
Company Name
▲▼
Period
▲▼
Period Year
▲▼
Min EPS
▲▼
Max EPS
▲▼
Estimate
▲▼
Min Rev
▲▼
Max Rev
▲▼
Revenue Estimate
▲▼
Get Alert
03/06/2024KIDS
OrthoPediatrics
FY2024———$197.00M$200.00M$182.90MGet Alert
01/08/2024KIDS
OrthoPediatrics
FY2023———$148.70M$148.70M$148.88MGet Alert
01/08/2024KIDS
OrthoPediatrics
Q42023———$37.60M$37.60M$37.77MGet Alert
01/08/2024KIDS
OrthoPediatrics
FY2024———$197.00M$200.00M$177.70MGet Alert
11/06/2023KIDS
OrthoPediatrics
FY2023———$148.00M$151.00M$149.17MGet Alert
07/31/2023KIDS
OrthoPediatrics
FY2023———$148.00M$151.00M$149.28MGet Alert
05/01/2023KIDS
OrthoPediatrics
FY2023———$148.00M$151.00M$147.32MGet Alert
02/28/2023KIDS
OrthoPediatrics
FY2023———$146.00M$149.00M$149.57MGet Alert
01/09/2023KIDS
OrthoPediatrics
FY2023———$146.00M$149.00M$151.82MGet Alert
01/09/2023KIDS
OrthoPediatrics
FY2022———$122.30M$122.30M$124.48MGet Alert
01/09/2023KIDS
OrthoPediatrics
Q42022———$31.00M$31.00M$33.18MGet Alert
10/31/2022KIDS
OrthoPediatrics
FY2022———$124.00M$125.00M$128.35MGet Alert
08/03/2022KIDS
OrthoPediatrics
FY2022———$127.00M$130.00M$124.45MGet Alert
07/05/2022KIDS
OrthoPediatrics
FY2022———$125.00M$128.00M$123.58MGet Alert
06/14/2022KIDS
OrthoPediatrics
FY2022———$125.00M$128.00M$123.15MGet Alert
05/04/2022KIDS
OrthoPediatrics
FY2022———$122.00M$125.00M$118.82MGet Alert
03/02/2022KIDS
OrthoPediatrics
FY2022———$118.00M$121.00M$119.19MGet Alert
01/10/2022KIDS
OrthoPediatrics
FY2021———$98.00M$98.00M$97.93MGet Alert
01/10/2022KIDS
OrthoPediatrics
Q42021———$24.80M$24.80M$24.71MGet Alert

FAQ

Q

What is the most recent guidance for OrthoPediatrics (KIDS)?

A

There have been no specific sales or earnings guidance reported for OrthoPediatrics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch